PCSA
Processa Pharmaceuticals, Inc.Company with tickers: PCSA
CIK
1533743
CUSIP
74275C403
Shares Outstanding
2,750,173
Investor Relations
https://www.processapharmaceuticals.com/investors
13F Activity (30d)
4 filings
4 filers
Share-repurchase activity from the company's own XBRL filings — cash spent on equity repurchases (common and preferred combined, as reported) per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $300,000 | 10-K, filed 2024-03-29 |
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $0 Δ | 10-K, filed 2024-03-29 |
| 2022-09-30 | $0 Δ | 10-Q, filed 2023-11-13 |
| 2022-06-30 | $0 Δ | 10-Q, filed 2023-08-10 |
| 2022-03-31 | $300,000 | 10-Q, filed 2023-05-15 |